FDA has approved Lipfendra, developed by American pharmaceutical company Merck, for adults with high LDL cholesterol. It ...

While tried-and-true high cholesterol treatments like statins are an important way to protect your heart if you have elevated ...

US regulators approved a first-of-its kind pill from Merck that is designed to help lower cholesterol levels beyond what ...

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.

A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...

Lipfendra is a new prescription cholesterol tablet from Merck. Its announced U.S. list price is $10.50 per tablet, which ...

Bengaluru: The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs ...

A new pill to treat stubbornly high cholesterol has been approved by the Food and Drug Administration, a development that ...

The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 ...

Lipfendra (enlicitide) offers a convenient option for adults who haven’t been able to lower their cholesterol sufficiently with statins. The U.S. Food and Drug Administration (FDA) approved Lipfendra ...